Literature DB >> 31852383

Establishing a patient centered, outpatient total joint home recovery program within an integrated healthcare system.

Paul David Weyker1,2, Christopher Allen-John Webb2,3,4.   

Abstract

Outpatient total joint home recovery (HR) is a rapidly growing initiative being developed and employed at high volume orthopedic centers. Minimally invasive surgery, improved pain control and home health services have made HR possible. Multidisciplinary teams with members ranging from surgeons and anesthesiologists to hospital administrators, physical therapists, nurses and research analysts are necessary for success. Eligibility criteria for outpatient total joint arthroplasty will vary between medical centers. Surgeon preference in addition to medical comorbidities, social support, preoperative patient mobility and safety of the HR location are all factors to consider when selecting patients for outpatient total joint HR. As additional knowledge is gained, the next steps will be to establish 'best practices' and speciality society-endorsed guidelines for patients undergoing outpatient total joint arthroplasty.

Entities:  

Keywords:  home recovery; multimodal analgesia; outpatient total joint arthroplasty; total hip arthroplasty; total joint arthroplasty; total knee arthroplasty

Mesh:

Year:  2019        PMID: 31852383     DOI: 10.2217/pmt-2019-0040

Source DB:  PubMed          Journal:  Pain Manag        ISSN: 1758-1869


  2 in total

1.  Neuraxial and general anesthesia for outpatient total joint arthroplasty result in similarly low rates of major perioperative complications: a multicentered cohort study.

Authors:  Edward Yap; Julia Wei; Christopher Webb; Kevin Ng; Matthias Behrends
Journal:  Reg Anesth Pain Med       Date:  2022-01-06       Impact factor: 6.288

2.  Factors influencing patients' preferences for their treating physician.

Authors:  Khalid S Alraddadi; Fayzah Al-Adwani; Ziad A Taher; Mubark Al-Mansour; Muhammad Khan
Journal:  Saudi Med J       Date:  2020-08       Impact factor: 1.484

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.